Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

2014 ◽  
Vol 17 (4) ◽  
pp. 264-273 ◽  
Author(s):  
P. García-Alfonso ◽  
J. García-Foncillas ◽  
R. Salazar ◽  
P. Pérez-Segura ◽  
R. García-Carbonero ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Medical Oncology ◽  
Spanish Society ◽  
Biomarker Testing ◽  
National Consensus

Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

2012 ◽  
Vol 14 (10) ◽  
pp. 726-739 ◽  
Author(s):  
Pilar García-Alfonso ◽  
Ramón Salazar ◽  
Jesús García-Foncillas ◽  
Eva Musulén ◽  
Rocío García-Carbonero ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Medical Oncology ◽  
Spanish Society ◽  
Biomarker Testing ◽  
National Consensus

Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

2013 ◽  
Vol 16 (4) ◽  
pp. 362-373 ◽  
Author(s):  
S. Martín-Algarra ◽  
M. T. Fernández-Figueras ◽  
J. A. López-Martín ◽  
A. Santos-Briz ◽  
A. Arance ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Medical Oncology ◽  
Spanish Society ◽  
Biomarker Testing ◽  
National Consensus

Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

2009 ◽  
Vol 11 (6) ◽  
pp. 363-375 ◽  
Author(s):  
Joan Albanell ◽  
Xavier Andreu ◽  
María José Calasanz ◽  
Ángel Concha ◽  
José María Corominas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Medical Oncology ◽  
Spanish Society ◽  
Her2 Testing ◽  
National Consensus

scholarly journals Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

2019 ◽  
Vol 22 (7) ◽  
pp. 989-1003 ◽  
Author(s):  
P. Garrido ◽  
E. Conde ◽  
J. de Castro ◽  
J. J. Gómez-Román ◽  
E. Felip ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Medical Oncology ◽  
Small Cell ◽  
Current Evidence ◽  
Small Cell Lung ◽  
Spanish Society ◽  
Joint Project ◽  
Biomarker Testing

Abstract In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) started a joint project to establish guidelines on biomarker testing in patients with advanced non-small-cell lung cancer (NSCLC) based on current evidence. As this field is constantly evolving, these guidelines have been updated, previously in 2012 and 2015 and now in 2019. Current evidence suggests that the mandatory tests to conduct in all patients with advanced NSCLC are for EGFR and BRAF mutations, ALK and ROS1 rearrangements and PD-L1 expression. The growing need to study other emerging biomarkers has promoted the routine use of massive sequencing (next-generation sequencing, NGS). The coordination of every professional involved and the prioritisation of the most suitable tests and technologies for each case remains a challenge.

Sign in / Sign up

Export Citation Format

Share Document